Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Neurogenic detrusor overactivity in patients with spinal cord injury: evaluation and management.

Literature DB >> 21964989

Neurogenic detrusor overactivity in patients with spinal cord injury: evaluation and management.

Arun Sahai¹, Eduardo Cortes, Jai Seth, Muhammad Shamim Khan, Jalesh Panicker, Cornelius Kelleher, Thomas M Kessler, Clare J Fowler, Prokar Dasgupta.

Abstract

Lower urinary tract dysfunction can have a significant impact on patients with spinal cord injury. Over the years, many treatment options have become available. This article reviews the assessment and management of neurogenic detrusor overactivity, with a particular focus on articles from the recent literature. Recent guidelines on the subject will be discussed. Management options include antimuscarinics and bladder emptying measures, botulinum toxin A, and neuromodulation in refractory cases and surgery for intractable cases. Recent and relevant publications in these areas will be summarized and discussed.

Entities: Disease Species

Mesh：

Substances：

Year: 2011 PMID： 21964989 DOI： 10.1007/s11934-011-0221-1

Source DB: PubMed Journal: Curr Urol Rep ISSN： 1527-2737 Impact factor: 3.092

57 in total

1. Medical and psychosocial complications associated with method of bladder management after traumatic spinal cord injury.

Authors: Anne P Cameron; Lauren P Wallner; Martin B Forchheimer; J Quentin Clemens; Rodney L Dunn; Gianna Rodriguez; David Chen; John Horton; Denise G Tate
Journal: Arch Phys Med Rehabil Date: 2011-01-31 Impact factor: 3.966

2. Fate of the leftover bladder after supravesical urinary diversion for benign disease.

Authors: Tajammul Fazili; Tahir R Bhat; Shikohe Masood; John H Palmer; G R Mufti
Journal: J Urol Date: 2006-08 Impact factor: 7.450

3. Cystectomy in patients with spinal cord injury: indications and long-term outcomes.

Authors: Janice N Cheng; Nathan Lawrentschuk; Dennis Gyomber; John Rogerson; Damien M Bolton
Journal: J Urol Date: 2010-05-15 Impact factor: 7.450

Review 4. Quality of life after cystectomy and urinary diversion: an evidence based analysis.

Authors: Elmar W Gerharz; Asa Månsson; Sonja Hunt; Eila C Skinner; Wiking Månsson
Journal: J Urol Date: 2005-11 Impact factor: 7.450

5. Neurogenic bladder treatment by doubling the recommended antimuscarinic dosage.

Authors: M Horstmann; T Schaefer; Y Aguilar; A Stenzl; K D Sievert
Journal: Neurourol Urodyn Date: 2006 Impact factor: 2.696

6. Trigonal injection of botulinum toxin-A does not cause vesicoureteral reflux in neurogenic patients.

Authors: Frederico Mascarenhas; Marcello Cocuzza; Cristiano Mendes Gomes; Nilo Leão
Journal: Neurourol Urodyn Date: 2008 Impact factor: 2.696

7. Patients' perspective of botulinum toxin-A as a long-term treatment option for neurogenic detrusor overactivity secondary to spinal cord injury.

Authors: Satoshi Hori; Prasad Patki; Kaka H Attar; Soran Ismail; Joana C Vasconcelos; P Julian R Shah
Journal: BJU Int Date: 2009-02-10 Impact factor: 5.588

Review 8. The neural control of micturition.

Authors: Clare J Fowler; Derek Griffiths; William C de Groat
Journal: Nat Rev Neurosci Date: 2008-06 Impact factor: 34.870

9. Effect of controlled-release oxybutynin on neurogenic bladder function in spinal cord injury.

Authors: Margie O'Leary; Janet R Erickson; Christopher P Smith; Charlotte McDermott; John Horton; Michael B Chancellor
Journal: J Spinal Cord Med Date: 2003 Impact factor: 1.985

Review 10. Types of indwelling urinary catheters for long-term bladder drainage in adults.

Authors: P Jahn; M Preuss; A Kernig; A Seifert-Hühmer; G Langer
Journal: Cochrane Database Syst Rev Date: 2007-07-18

13 in total

Review 1. OnabotulinumtoxinA (Botox(®)): a review of its use in the treatment of urinary incontinence in patients with multiple sclerosis or subcervical spinal cord injury.

Authors: Mark Sanford
Journal: Drugs Date: 2014-09 Impact factor: 9.546

Review 2. The evaluation and management of refractory neurogenic overactive bladder.

Authors: Raj Kurpad; Michael J Kennelly
Journal: Curr Urol Rep Date: 2014-10 Impact factor: 3.092

Review 3. Recommendations for urological follow-up of patients with neurogenic bladder secondary to spinal cord injury.

Authors: Mikolaj Przydacz; Piotr Chlosta; Jacques Corcos
Journal: Int Urol Nephrol Date: 2018-03-22 Impact factor: 2.370

4. The possible role of percutaneous tibial nerve stimulation using adhesive skin surface electrodes in patients with neurogenic detrusor overactivity secondary to spinal cord injury.

Authors: Guoqing Chen; Limin Liao; Yao Li
Journal: Int Urol Nephrol Date: 2015-01-22 Impact factor: 2.370

5. Long-term clinical and urodynamic effectiveness of augmentation ileocystoplasty with supra-trigonal cystectomy in individuals with spinal cord injury.

Authors: A Balanca; A Even; C Malot; E Chartier-Kastler; P Denys; C Joussain
Journal: World J Urol Date: 2022-06-10 Impact factor: 3.661

9. Early Fesoterodine Fumarate Administration Prevents Neurogenic Detrusor Overactivity in a Spinal Cord Transected Rat Model.

Authors: Xavier Biardeau; Mikolaj Przydacz; Shachar Aharony; George Loutochin; Lysanne Campeau; Maeva Kyheng; Jacques Corcos
Journal: PLoS One Date: 2017-01-06 Impact factor: 3.240

10. Management of lower urinary tract dysfunction in patients with neurological disorders.

Authors: Wen Ji Li; Seung-June Oh
Journal: Korean J Urol Date: 2012-09-19